The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure - Wikidata - awgldk - TriplyDB

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

http://www.wikidata.org/entity/Q24607362

about

Recent developments in adenosine receptor ligands and their potential as novel drugs Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.Dopamine, effort, and decision making: theoretical comment on Bardgett et al. (2009).Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation.Xanthines as adenosine receptor antagonists.Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism.Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists.Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia.Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.Dopamine/adenosine interactions involved in effort-related aspects of food motivation Dopamine, behavioral economics, and effort.Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders.The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Neural substrates underlying effort, time, and risk-based decision making in motivated behavior.Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.Dopamine and Stress System Modulation of Sex Differences in Decision Making.Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Activation of adenosine A₂A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation.Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.Caffeine Modulates Food Intake Depending on the Context That Gives Access to Food: Comparison With Dopamine Depletion

P2860

Q27687253-D12E0D8A-650D-4948-A6B2-9519B52BA59C Q28484509-493DA902-081F-4B47-B12D-C7917949D954 Q30457808-627AD1B2-69A5-49C4-BD57-466E3C3F8CA3 Q33591276-26834ABC-9728-4ED1-A4DF-9AD807DBD1F7 Q33635725-8C9A8C51-5C96-49F6-813B-73A4AEECB802 Q33648162-72010C78-3333-40D2-A131-94AA3A2D7958 Q34139398-C8494185-EA5E-4148-8119-6841B67BA620 Q34337032-79338BA4-9839-48CE-B415-ECDAC6661572 Q34802194-59DB6CE5-2A18-4890-A514-2345C2735EA3 Q35189617-24DC79CA-D978-4CAE-830A-21A91134545C Q35203638-1F662B7C-492A-4DB4-9C63-36D7E5036909 Q35489240-3993F8A0-B6F4-4F9A-95F0-85F1BB1C1DA6 Q35706890-35DC96FC-2A07-4E56-B1A0-74F33C93B120 Q35746360-7D9C3937-58E4-4736-A81C-3C05BC2A58EE Q36466181-A868D178-57B8-462A-BC52-02235371FFE4 Q37360680-4DF394E0-70B7-442A-87B3-A55FD875FBCB Q37362447-9C2141A3-8011-494A-8601-53BAE0E83C71 Q37563696-F9857BC5-9D2F-4071-AF36-511D883F6381 Q37614233-5584698B-D662-402C-9641-83DB56FE35AD Q37963718-59671D4D-4158-43CF-A084-5FC3E6828C19 Q37979784-FEC9C0BB-5937-4C09-8818-B50B5379F4A9 Q38836831-292AE1EB-1CFF-490E-8736-B7B55271A6A8 Q38900272-B87EF41F-6FAE-43AC-AB1D-0A328139A662 Q40093821-8BA6141B-F65E-481D-87B9-2313CC3B7CB6 Q40109493-B2FAAD36-0C8C-4B2E-B624-2DA2641A3AB8 Q43096386-D0BB4ACE-40F0-49A4-852D-B0F1BAEC481F Q47372013-E2A9634F-61BF-41FF-B24C-ED440C641E86 Q47586487-3596D4FB-8518-4D86-84F3-5D2DF437ABCB Q47596751-286120B1-F153-462C-9F65-0923ED97D7A5 Q47680336-55902C59-9E87-438E-859D-46A7FD42EDAE Q48190081-D500DA43-F607-476F-833C-6B6DB3A56738 Q52599712-E551245E-3D87-40D8-8F9B-69B9760C0A71 Q55132660-84F6877E-5897-48D0-BB98-4CC2D6C9FE66 Q58761397-9C343D29-8A7B-40CC-9EBE-85F3C97C9280

P2860

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

http://www.wikidata.org/entity/Q24607362

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@ast

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@en

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@nl

type

label

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@ast

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@en

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@nl

prefLabel

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@ast

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@en

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@nl

P1433

Q24607362-113E2643-FB0B-4D4C-9EC6-A8C056248C7E

P1476

Q24607362-072832D8-C08F-4ED5-A75C-863DAC8FEF88

P2093

Q24607362-2DE852A6-F9F7-41E7-B45C-1CC958C2A0BC

Q24607362-578F71B0-D67D-43AD-B967-F52CF50FAC92

Q24607362-598E8DCE-4DB5-4341-BFC4-3CC99E5D2EDE

Q24607362-967776E0-15D0-4AA5-B2ED-9F9026D2932E

Q24607362-AC0A080A-FFB1-421E-B423-2293CFF8A9BC

Q24607362-C34CFEE0-306B-4C5F-9383-13C6327D8FB3

Q24607362-C6150B7A-D62F-41FD-BCDF-212A3E8764D8

Q24607362-E936D3C0-65AC-482B-A779-DABA7A950CB5

P2860

Q24607362-0832ED82-3F3E-437A-9258-F0D093A56342

Q24607362-0891486C-B216-42EF-9F18-E3DD49056CF0

Q24607362-093A6102-941D-46BF-8E22-8C17F691F60A

Q24607362-0B9524F8-0E1D-492E-82FE-0B9587FC5F45

Q24607362-0D8A70B5-EB94-452B-A678-E7353787499E

Q24607362-0E104840-AA06-4BB6-B91C-06897B728759

Q24607362-0E68172D-FD3D-42AF-9705-BBF654BD744D

Q24607362-15466D71-4923-4994-9529-2F1E85611AC9

Q24607362-196D1AE0-3A0F-4FCC-A17E-EC835AFD7180

Q24607362-20DB22AB-AE94-426A-A5E3-1B2F61292181

P2888

Q24607362-7FB8EE58-BE6A-462A-879D-26DF69B3018F

P304

Q24607362-7B8166AE-BFE7-4E1E-A6CC-1BB7E3CC857C

P31

Q24607362-A4F43B00-D3DE-4E48-8D65-0795D5240B5A

P356

Q24607362-5C9C837D-B526-4833-B56C-68047E4ACC9A

P407

Q24607362-D69A8075-B24A-4548-973F-6F55589CC60C

P433

Q24607362-4F1FFB4F-2E1D-4D0F-B36D-BABB0530BE66

P478

Q24607362-E2A7DEAE-F4E9-460F-A3DC-2A3B905C94E3

P577

Q24607362-682AA6E5-D5EC-4815-8645-9FC6B5547E66

P5875

Q24607362-B9B4516D-1E06-416F-B725-A8E9199DA7B2

P6179

Q24607362-09C755BC-261C-453A-94A8-804B12D7B8DE

P698

Q24607362-7BDDB7A9-4432-4998-8D96-225B74CA95B2

P921

Q24607362-70a22cde-cd9f-4537-a437-57027fdc45c4

P932

Q24607362-4AAC0984-8265-45A4-82F3-2E7D7DC1981D

P356

S00213-008-1441-Z

P1433

Psychopharmacology

P1476

The adenosine A2A antagonist M ...... T-maze cost/benefit procedure

@en

P2093

Allison M Mott

http://www.w3.org/2001/XMLSchema#string

Christa E Müller

http://www.w3.org/2001/XMLSchema#string

Eric J Nunes

http://www.w3.org/2001/XMLSchema#string

John D Salamone

http://www.w3.org/2001/XMLSchema#string

Jörg Hockemeyer

http://www.w3.org/2001/XMLSchema#string

Kelly S Sink

http://www.w3.org/2001/XMLSchema#string

Lyndsey E Collins

http://www.w3.org/2001/XMLSchema#string

Russell G Port

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain

Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists

Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test

Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior.

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum.

Mood disorders.

Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.

P2888

s00213-008-1441-z

P304

103-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-008-1441-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23767108

http://www.w3.org/2001/XMLSchema#string

P6179

1006048339

http://www.w3.org/2001/XMLSchema#string

P698

19132351

http://www.w3.org/2001/XMLSchema#string

P921

P932

2875244

http://www.w3.org/2001/XMLSchema#string